Pancreatic Glucagon-Producing Neuroendocrine Tumor

Pancreatic Glucagon-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02831179	Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	withdrawn	Phase 1	0	Vanderbilt-Ingram Cancer CenterOTHER	0	Sep 28, 2017	clinicaltrials
NCT02108782	Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors	withdrawn	Phase 2	0	Academic and Community Cancer Research UnitedOTHER	0	Jul 19, 2017	clinicaltrials

Data updated 23 days agoSource updated Sep 28, 2017source: clinicaltrials